Zacks Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-11,452
| Closed | -$826K | – | 667 |
|
|
2023
Q2 | $826K | Buy |
11,452
+1,479
| +15% | +$107K | 0.01% | 399 |
|
|
2023
Q1 | $734K | Buy |
+9,973
| New | +$734K | 0.01% | 410 |
|
|
2020
Q4 | – | Sell |
-6,428
| Closed | -$382K | – | 554 |
|
|
2020
Q3 | $382K | Buy |
6,428
+83
| +1% | +$4.93K | 0.01% | 429 |
|
|
2020
Q2 | $443K | Buy |
+6,345
| New | +$443K | 0.01% | 401 |
|
|
2019
Q1 | – | Sell |
-11,522
| Closed | -$975K | – | 574 |
|
|
2018
Q4 | $975K | Sell |
11,522
-1,626
| -12% | -$138K | 0.02% | 349 |
|
|
2018
Q3 | $2.25M | Sell |
13,148
-1,184
| -8% | -$203K | 0.05% | 250 |
|
|
2018
Q2 | $1.85M | Buy |
+14,332
| New | +$1.85M | 0.04% | 290 |
|
|
2018
Q1 | – | Sell |
-13,276
| Closed | -$1.13M | – | 576 |
|
|
2017
Q4 | $1.13M | Sell |
13,276
-766
| -5% | -$65.4K | 0.02% | 374 |
|
|
2017
Q3 | $1.19M | Buy |
+14,042
| New | +$1.19M | 0.03% | 338 |
|
|
2016
Q2 | – | Sell |
-3,943
| Closed | -$263K | – | 679 |
|
|
2016
Q1 | $263K | Buy |
+3,943
| New | +$263K | 0.01% | 516 |
|
|
2015
Q4 | – | Sell |
-5,535
| Closed | -$296K | – | 613 |
|
|
2015
Q3 | $296K | Buy |
+5,535
| New | +$296K | 0.01% | 513 |
|